Characterized as a systemic inflammatory response, CRS typically arises from the on-target effects of BsAbs binding simultaneously to their antigenic targets on effector and plasma cells, which leads to the release of cytokines like Interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α) (23). Here, IFNG is linked to congenital rubella syndrome.